Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Journal:
The New England journal of medicine, Volume: 367, Issue: 16Abstract:
Linezolid has antimycobacterial activity in vitro and is increasingly used for patients with highly drug-resistant tuberculosis.
Courtesy of the U.S. National Library of Medicine